Undervalued Medical Device & Instrument Stocks on NYS February 2025

February 16, 2025

Medical Devices & Instruments

Companies in the Medical Devices & Instruments industry develop, manufacture, and market medical and surgical equipment or instruments and supplies.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Medical Devices & Instruments stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
AVNS Avanos Medical 16.57 32.36 95.27 473532 772 0.00 35.3
NVRO Nevro 5.71 9.69 69.67 1410489 213 0.00 0.0
ALUR Allurion Technologies 5.15 5.83 13.26 3991396 13 0.00 0.0
All data provided as at market close February 13, 2025.

Company Details

Avanos Medical

AVNS:NYS

Close Price

16.57

Our Valuation

32.36

% Difference

95.27

Market Cap ($M)

772

P/E Ratio

35.3

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients.

Access the stockcalc valuation


Nevro

NVRO:NYS

Close Price

5.71

Our Valuation

9.69

% Difference

69.67

Market Cap ($M)

213

P/E Ratio

0.0

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients.

Access the stockcalc valuation


Allurion Technologies

ALUR:NYS

Close Price

5.15

Our Valuation

5.83

% Difference

13.26

Market Cap ($M)

13

P/E Ratio

0.0

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS.

Access the stockcalc valuation


Avanos Medical and Nevro are the most undervalued Medical Devices & Instruments stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nys-february-2025
Avanos Medical $AVNS and Nevro $NVRO are the most undervalued Medical Devices & Instruments stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nys-february-2025
Avanos Medical and Nevro are the most undervalued Medical Devices & Instruments stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nys-february-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.